Perspective Therapeutics Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.5% | 104.2% | 95.6% | 100.1% | 77.1% | 63.6% | 78.1% | 65.4% | 61.3% | 72.7% | 66.5% | 59.8% | 54.3% | 54.3% | 46.6% | 49.6% | 40.8% | 53.0% | 47.7% | 50.5% | 47.6% | 50.3% | 50.5% | 63.0% | 75.9% | 78.0% | 86.1% | 913.3% | 88.1% | – | 75.7% | 109.5% | – | – | 181.3% | 252.8% | 370.8% | 2,351.2% | 1,481.6% | 1,390.1% | 987.3% | |
| 5.5% | -4.2% | 4.4% | -0.1% | 22.9% | 36.4% | 21.9% | 34.6% | 38.7% | 27.3% | 33.5% | 40.2% | 45.7% | 45.7% | 53.4% | 50.4% | 59.2% | 47.0% | 52.3% | 49.5% | 52.4% | 49.7% | 49.5% | 37.0% | 24.1% | 22.0% | 13.9% | -813.3% | 11.9% | – | 24.3% | -9.5% | -81.3% | -203.0% | -81.3% | -152.8% | -270.8% | -2,251.2% | -1,381.6% | 100.0% | -612.0% | |
| 15.3% | 12.7% | 15.9% | 14.6% | 25.5% | 23.1% | 29.9% | 22.1% | 30.1% | 35.7% | 26.9% | 21.7% | 15.5% | 17.7% | 10.1% | 12.6% | 10.2% | 14.1% | 13.1% | 12.1% | 13.9% | 17.3% | 18.9% | 31.8% | 41.2% | 33.4% | 210.8% | 913.3% | 270.7% | – | 1,939.5% | 2,292.9% | 3,259.6% | 5,505.6% | 3,078.3% | 4,197.9% | 9,731.6% | 76,567.4% | 26,639.5% | 26,597.5% | 23,240.3% | |
| 75.8% | 89.4% | 85.8% | 85.6% | 64.4% | 93.8% | 69.4% | 64.1% | 49.8% | 97.0% | 62.3% | 57.8% | 57.1% | 51.9% | 47.4% | 48.5% | 40.1% | 54.8% | 44.8% | 47.9% | 45.5% | 48.4% | 54.3% | 63.2% | 181.4% | 118.7% | 383.8% | 848.1% | 224.9% | – | 2,129.7% | 1,696.6% | 1,890.2% | 3,523.9% | 2,125.2% | 2,658.3% | 3,699.0% | 16,165.1% | 9,190.8% | 9,623.5% | 7,203.4% | |
| 116.2% | 107.7% | 150.1% | 143.8% | 131.2% | 172.3% | 150.0% | 130.1% | 123.8% | 175.1% | 130.7% | 116.4% | 106.2% | 105.1% | 89.5% | 91.3% | 78.3% | 99.2% | 82.2% | 86.5% | 81.8% | 90.0% | 96.8% | 121.0% | 269.2% | 196.5% | 626.2% | 845.6% | 557.3% | – | 3,556.9% | 3,992.0% | 5,049.9% | 19,223.9% | 4,968.6% | 8,136.6% | 13,059.8% | 92,632.6% | 35,830.3% | 36,221.0% | 30,243.8% | |
| -110.7% | -111.9% | -145.7% | -143.9% | -108.3% | -136.0% | -128.2% | -95.6% | -85.1% | -147.8% | -97.2% | -75.1% | -60.4% | -59.5% | -36.1% | -40.9% | -19.0% | -52.2% | -29.9% | -37.0% | -29.5% | -40.3% | -47.3% | -84.1% | -245.1% | -174.6% | -612.3% | -1,658.8% | -545.5% | – | -3,532.6% | -4,001.5% | -5,049.9% | -19,223.9% | -5,049.9% | -8,289.3% | -13,330.6% | -92,632.6% | -37,211.8% | -36,121.0% | -30,619.1% | |
| 6.4% | 2.6% | 2.7% | 0.9% | 1.7% | 29.3% | 0.6% | 5.3% | 4.8% | 0.9% | 2.3% | 8.6% | 1.0% | 12.4% | 0.1% | 1.8% | 0.0% | 4.1% | 5.7% | 8.9% | 1.2% | 21.2% | 4.8% | 16.0% | 8.2% | 21.8% | 1.0% | 4.4% | 1.3% | – | 5.1% | 8.9% | 18.7% | 31.2% | 18.7% | 41.0% | 31.1% | 148.8% | 138.2% | 87.7% | 74.6% | |
| -99.7% | -105.8% | -138.6% | -141.1% | -106.1% | -135.3% | -127.7% | -95.2% | -84.7% | -147.1% | -96.5% | -74.3% | -58.6% | -56.9% | -35.2% | -40.7% | -18.9% | -52.1% | -29.9% | -36.8% | -28.7% | -39.2% | -46.3% | -83.0% | -236.9% | -158.1% | -594.0% | -1,613.3% | -531.9% | – | -3,468.1% | -3,637.8% | -4,098.1% | -18,062.4% | -4,098.1% | -7,585.9% | -12,425.4% | -89,030.2% | -34,459.2% | -33,070.4% | -28,662.1% | |
| -6.4% | -2.6% | -2.7% | -0.9% | 1.7% | -29.3% | -0.6% | 5.3% | 4.8% | -0.9% | -2.3% | -8.6% | -1.0% | -12.4% | -0.1% | 1.8% | 0.0% | -4.1% | -5.7% | -8.9% | -1.2% | -21.2% | -4.8% | -2.6% | -8.2% | -38.3% | -573.8% | -36.6% | 13.3% | – | – | -18.8% | – | -896.2% | – | -723.1% | – | -1,844.2% | – | 242.0% | – | |
| -99.7% | -105.8% | -138.6% | -141.1% | -106.1% | -135.3% | -127.7% | -95.2% | -84.7% | -147.1% | -96.5% | -74.3% | -58.6% | -56.9% | -35.2% | -40.7% | -18.9% | -52.1% | -29.9% | -36.8% | -28.7% | -39.2% | -46.3% | -83.0% | -236.9% | -119.8% | -20.3% | -1,888.8% | -531.9% | – | -3,752.2% | -3,779.7% | -4,098.1% | -17,166.2% | -4,098.1% | -7,408.6% | -12,425.4% | -87,186.0% | -34,459.2% | -33,069.1% | -28,468.0% | |
| -94.7% | -102.1% | -146.7% | -141.1% | -106.9% | -135.3% | -126.7% | -95.6% | -83.9% | -147.1% | -95.1% | -77.5% | -60.6% | -59.5% | -34.5% | -39.2% | -17.8% | -50.7% | -28.5% | -35.1% | -28.0% | -38.8% | -45.1% | -81.5% | -241.1% | -169.2% | -582.0% | -1,614.1% | -518.7% | – | -3,456.9% | -3,892.0% | -3,898.1% | -17,785.5% | -4,868.6% | -7,292.1% | -12,023.4% | -86,530.2% | -35,730.3% | -32,982.7% | -28,412.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.